Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!
Ann Transl Med
.
2019 Dec;7(Suppl 8):S270.
doi: 10.21037/atm.2019.12.33.
Author
Andreas Goette
1
Affiliation
1
Department of Cardiology and Intensive Care Medicine, St. Vincenz Hospital, Paderborn, Germany.
PMID:
32015989
PMCID:
PMC6976507
DOI:
10.21037/atm.2019.12.33
No abstract available
Publication types
Editorial
Comment